Posted inCardiagtech

Nursing Diagnosis and Care Plan for Diastolic Heart Failure: A Comprehensive Guide

No Comments

Heart failure (HF) is a pervasive global health issue, affecting millions and posing significant challenges to healthcare systems. It’s not a singular disease but a complex clinical syndrome arising from structural or functional cardiac disorders that impair the heart’s ability to fill with or eject blood effectively. While often perceived as a condition of weakened pumping, heart failure also frequently stems from the heart’s inability to relax and fill properly – a condition known as diastolic heart failure, or heart failure with preserved ejection fraction (HFpEF). This article delves into the critical aspects of Nursing Diagnosis And Care Plan For Diastolic Heart Failure, providing an in-depth guide for healthcare professionals.

Understanding Diastolic Heart Failure (HFpEF)

Diastolic heart failure, or HFpEF, is characterized by a preserved left ventricular ejection fraction (LVEF), typically greater than 50%, alongside signs and symptoms of heart failure. The fundamental problem in HFpEF lies in the impaired relaxation and filling of the left ventricle during diastole. This stiffness prevents the ventricle from adequately filling with blood, leading to increased filling pressures and ultimately, heart failure symptoms.

While systolic heart failure (HFrEF), characterized by reduced ejection fraction, has been extensively studied and targeted with therapies, diastolic heart failure presents a more complex and less understood landscape. Effective nursing diagnosis and care plan for diastolic heart failure are crucial for improving patient outcomes and quality of life.

Key Nursing Diagnoses for Diastolic Heart Failure

Nurses play a pivotal role in the management of diastolic heart failure. Accurate nursing diagnoses are the foundation for developing effective care plans. Based on the pathophysiology and clinical manifestations of HFpEF, common nursing diagnoses include:

  • Decreased Cardiac Output related to impaired ventricular filling: This is a primary diagnosis in diastolic heart failure. The stiff ventricle reduces stroke volume, leading to inadequate cardiac output to meet the body’s metabolic demands.
  • Excess Fluid Volume related to sodium and water retention secondary to heart failure: Neurohormonal responses in heart failure lead to fluid retention, exacerbating symptoms like edema and dyspnea.
  • Activity Intolerance related to decreased cardiac output and dyspnea: Reduced cardiac output and pulmonary congestion contribute to fatigue and shortness of breath, limiting the patient’s ability to perform activities of daily living.
  • Impaired Gas Exchange related to pulmonary congestion: Fluid accumulation in the lungs impairs oxygen diffusion, leading to hypoxemia and dyspnea.
  • Fatigue related to decreased cardiac output and increased work of breathing: Heart failure-induced fatigue is a significant symptom impacting quality of life.
  • Anxiety related to dyspnea, chronic illness, and fear of death: The chronic and progressive nature of heart failure, coupled with distressing symptoms, can induce significant anxiety.
  • Knowledge Deficit related to disease process, medication regimen, and lifestyle modifications: Patients with diastolic heart failure require comprehensive education to manage their condition effectively.
  • Risk for Falls related to weakness, dizziness, and medication side effects: Older adults with heart failure are at increased risk of falls.
  • Ineffective Health Management related to complexity of treatment regimen and lifestyle changes: Adhering to complex medication schedules and lifestyle modifications can be challenging for patients.

Crafting a Nursing Care Plan for Diastolic Heart Failure

A comprehensive nursing care plan for diastolic heart failure should be individualized, patient-centered, and address the specific nursing diagnoses identified. It should encompass the following key components:

1. Assessment: A Foundation for Care

Thorough assessment is the cornerstone of effective nursing care. For diastolic heart failure, the assessment should focus on:

  • Detailed History and Physical Examination:

    • Symptoms: Assess for dyspnea (especially exertional and paroxysmal nocturnal dyspnea), orthopnea, fatigue, edema (peripheral, pulmonary), abdominal distension, and cough. Pay attention to the NYHA functional class to gauge symptom severity.
    • Cardiovascular Assessment: Auscultate heart sounds for S3 or S4 gallops, murmurs. Assess for jugular venous distension (JVD). Check for pulsus alternans.
    • Respiratory Assessment: Auscultate lung sounds for crackles (rales), wheezes. Assess respiratory rate, depth, and effort.
    • Edema Assessment: Evaluate for peripheral edema (location, severity, pitting vs. non-pitting). Assess for pulmonary edema signs (cough, frothy sputum).
    • Vital Signs: Monitor heart rate, blood pressure, respiratory rate, oxygen saturation.
    • Weight: Daily weight monitoring is crucial to detect fluid retention.

  • Review of Diagnostic Tests:

    • Echocardiogram: Crucial for confirming preserved ejection fraction and evaluating diastolic function parameters (e.g., E/A ratio, E/e’).
    • ECG: To identify arrhythmias, ischemia, or previous MI.
    • Chest X-ray: To assess for cardiomegaly, pulmonary congestion, and pleural effusions.
    • Blood Tests: BNP or NT-proBNP levels are elevated in heart failure. Electrolytes, renal function, liver function, and thyroid function tests are also important.

2. Nursing Interventions: Addressing Key Needs

Nursing interventions for diastolic heart failure are aimed at managing symptoms, improving cardiac function, preventing complications, and enhancing quality of life.

  • Managing Fluid Volume Excess:

    • Administer Diuretics: Loop diuretics (e.g., furosemide, bumetanide) are commonly used to reduce fluid overload. Monitor electrolyte levels, especially potassium.
    • Fluid Restriction: Mild to moderate fluid restriction (around 2 liters per day) may be recommended, especially in patients with hyponatremia or persistent fluid overload.
    • Sodium Restriction: Dietary sodium restriction (2-3 grams per day) is essential to minimize fluid retention. Educate patients on sodium content in foods.
    • Monitor Daily Weight: Instruct patients to monitor their weight daily and report significant gains (e.g., 2-3 pounds in a day or 5 pounds in a week).
    • Positioning: Elevate the head of the bed to promote venous return and reduce orthopnea.

  • Improving Cardiac Output:

    • Medication Management: Administer medications as prescribed, which may include:
      • Beta-blockers: To control heart rate and improve diastolic filling time.
      • ACE inhibitors or ARBs: To manage hypertension and reduce afterload.
      • Mineralocorticoid Receptor Antagonists (MRAs): Such as spironolactone or eplerenone, to reduce fluid retention and improve outcomes.
      • Angiotensin Receptor-Neprilysin Inhibitor (ARNI): Sacubitril/valsartan may be considered in select patients.
      • SGLT2 inhibitors: Emerging evidence supports their use in HFpEF to improve outcomes and reduce hospitalizations.
    • Monitor Hemodynamics: Assess blood pressure, heart rate, and rhythm regularly. Report any significant changes.

  • Enhancing Activity Tolerance:

    • Gradual Exercise Program: Encourage a structured, gradual exercise program tailored to the patient’s functional capacity. Cardiac rehabilitation may be beneficial.
    • Energy Conservation Techniques: Teach patients energy-saving techniques for daily activities.
    • Rest Periods: Advise patients to schedule rest periods between activities to reduce fatigue.

  • Promoting Gas Exchange:

    • Oxygen Therapy: Administer supplemental oxygen as needed to maintain adequate oxygen saturation.
    • Positioning: High Fowler’s position can improve lung expansion.
    • Monitor Respiratory Status: Assess respiratory rate, depth, effort, and breath sounds frequently.
    • Pulmonary Hygiene: Encourage coughing and deep breathing exercises to prevent atelectasis.

  • Reducing Anxiety:

    • Therapeutic Communication: Provide emotional support, listen actively to patient concerns, and address anxieties.
    • Relaxation Techniques: Teach relaxation techniques such as deep breathing, guided imagery, or meditation.
    • Anxiolytics (if prescribed): Administer anxiolytic medications as ordered and monitor for side effects.
    • Referral to Counseling: Consider referral to a mental health professional if anxiety is severe or persistent.

  • Patient Education: A cornerstone of the nursing care plan for diastolic heart failure is comprehensive patient education.

    • Disease Process: Explain diastolic heart failure in simple terms, emphasizing the heart’s filling problem and the importance of managing contributing factors like hypertension and diabetes.
    • Medication Management: Thoroughly educate patients about each medication: name, purpose, dosage, schedule, side effects, and importance of adherence. Use pill boxes, reminders, and written instructions to improve compliance.
    • Dietary Modifications: Provide detailed instructions on sodium restriction and fluid management. Offer practical tips for low-sodium meal planning.
    • Activity and Exercise: Discuss the importance of regular, moderate exercise and provide guidelines for safe activity levels.
    • Symptom Monitoring: Educate patients on recognizing worsening heart failure symptoms (increased dyspnea, edema, weight gain, fatigue) and when to seek medical attention promptly.
    • Daily Weight Monitoring: Instruct on proper technique and the importance of reporting weight changes.
    • Smoking Cessation and Alcohol Moderation: Provide resources and support for smoking cessation and advise on alcohol consumption limits.
    • Importance of Follow-up: Emphasize the need for regular follow-up appointments with their healthcare provider.

3. Evaluation: Measuring Outcomes

Regularly evaluate the effectiveness of the nursing care plan. Expected patient outcomes may include:

  • Improved Cardiac Output: Evidenced by stable vital signs, adequate urine output, and reduced symptoms of low cardiac output.
  • Reduced Fluid Volume Excess: Demonstrated by decreased edema, stable weight, and improved breathing.
  • Increased Activity Tolerance: Patient reports less fatigue and dyspnea with activity, able to participate in desired activities.
  • Improved Gas Exchange: Oxygen saturation within normal limits, reduced dyspnea.
  • Decreased Anxiety: Patient expresses reduced anxiety and utilizes coping mechanisms effectively.
  • Increased Knowledge: Patient verbalizes understanding of diastolic heart failure, medications, and self-management strategies.
  • Reduced Risk for Falls: Patient demonstrates safe ambulation and utilizes fall prevention strategies.
  • Effective Health Management: Patient adheres to medication regimen, lifestyle modifications, and follow-up appointments.

Interprofessional Collaboration

Optimal care for patients with diastolic heart failure requires a collaborative approach. Nurses work closely with:

  • Physicians (Cardiologists, Primary Care): To implement medical management, adjust medications, and coordinate overall care.
  • Pharmacists: To ensure medication optimization, address drug interactions, and provide patient education on medications.
  • Dietitians: To develop individualized dietary plans for sodium and fluid restriction.
  • Physical and Occupational Therapists: To design exercise programs and address activity limitations.
  • Social Workers and Case Managers: To assist with resources, support services, and discharge planning.
  • Cardiac Rehabilitation Team: To provide structured exercise programs, education, and support.

Conclusion

Diastolic heart failure presents unique challenges in diagnosis and management. A well-developed nursing diagnosis and care plan for diastolic heart failure is essential for providing holistic, patient-centered care. By focusing on accurate assessment, targeted interventions, comprehensive patient education, and interprofessional collaboration, nurses can significantly improve the outcomes and quality of life for individuals living with this complex condition. Ongoing research and evolving clinical guidelines continue to shape our understanding and management of diastolic heart failure, highlighting the need for continuous learning and adaptation in nursing practice.


Figure: Chest radiograph illustrating congestive heart failure, a common finding in both systolic and diastolic heart failure, showing pulmonary congestion.

References

  1. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW., ACC/AHA Joint Committee Members. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 03;145(18):e895-e1032. PubMed: 35363499
  2. Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016 Jun;13(6):368-78. PMC free article: PMC4868779 PubMed: 26935038
  3. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987 Jun 04;316(23):1429-35. PubMed: 2883575
  4. Lind L, Ingelsson M, Sundstrom J, Ärnlöv J. Impact of risk factors for major cardiovascular diseases: a comparison of life-time observational and Mendelian randomisation findings. Open Heart. 2021 Sep;8(2) PMC free article: PMC8438838 PubMed: 34518286
  5. Noubiap JJ, Agbor VN, Bigna JJ, Kaze AD, Nyaga UF, Mayosi BM. Prevalence and progression of rheumatic heart disease: a global systematic review and meta-analysis of population-based echocardiographic studies. Sci Rep. 2019 Nov 19;9(1):17022. PMC free article: PMC6863880 PubMed: 31745178
  6. Kim KH, Pereira NL. Genetics of Cardiomyopathy: Clinical and Mechanistic Implications for Heart Failure. Korean Circ J. 2021 Oct;51(10):797-836. PMC free article: PMC8484993 PubMed: 34327881
  7. Rezkalla SH, Kloner RA. Viral myocarditis: 1917-2020: From the Influenza A to the COVID-19 pandemics. Trends Cardiovasc Med. 2021 Apr;31(3):163-169. PMC free article: PMC7965406 PubMed: 33383171
  8. Muchtar E, Blauwet LA, Gertz MA. Restrictive Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. Circ Res. 2017 Sep 15;121(7):819-837. PubMed: 28912185
  9. Shams P, Ahmed I. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jul 30, 2023. Cardiac Amyloidosis. PubMed: 35593829
  10. Brown KN, Pendela VS, Ahmed I, Diaz RR. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jul 30, 2023. Restrictive Cardiomyopathy. PubMed: 30725919
  11. Matta AG, Carrié D. Epidemiology, Pathophysiology, Diagnosis, and Principles of Management of Takotsubo Cardiomyopathy: A Review. Med Sci Monit. 2023 Mar 06;29:e939020. PMC free article: PMC9999670 PubMed: 36872594
  12. Bairashevskaia AV, Belogubova SY, Kondratiuk MR, Rudnova DS, Sologova SS, Tereshkina OI, Avakyan EI. Update of Takotsubo cardiomyopathy: Present experience and outlook for the future. Int J Cardiol Heart Vasc. 2022 Apr;39:100990. PMC free article: PMC8913320 PubMed: 35281752
  13. Ahmad SA, Brito D, Khalid N, Ibrahim MA. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): May 22, 2023. Takotsubo Cardiomyopathy. PubMed: 28613549
  14. DeFilippis EM, Beale A, Martyn T, Agarwal A, Elkayam U, Lam CSP, Hsich E. Heart Failure Subtypes and Cardiomyopathies in Women. Circ Res. 2022 Feb 18;130(4):436-454. PMC free article: PMC10361647 PubMed: 35175847
  15. Wong CM, Hawkins NM, Jhund PS, MacDonald MR, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Petrie MC, McMurray JJ. Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity). J Am Coll Cardiol. 2013 Nov 12;62(20):1845-54. PubMed: 23850914
  16. Sciomer S, Moscucci F, Salvioni E, Marchese G, Bussotti M, Corrà U, Piepoli MF. Role of gender, age and BMI in prognosis of heart failure. Eur J Prev Cardiol. 2020 Dec;27(2_suppl):46-51. PMC free article: PMC7691623 PubMed: 33238736
  17. Volpe M, Gallo G. Obesity and cardiovascular disease: An executive document on pathophysiological and clinical links promoted by the Italian Society of Cardiovascular Prevention (SIPREC). Front Cardiovasc Med. 2023;10:1136340. PMC free article: PMC10040794 PubMed: 36993998
  18. Kim DY, Kim SH, Ryu KH. Tachycardia induced Cardiomyopathy. Korean Circ J. 2019 Sep;49(9):808-817. PMC free article: PMC6713829 PubMed: 31456374
  19. Anakwue RC, Onwubere BJ, Anisiuba BC, Ikeh VO, Mbah A, Ike SO. Congestive heart failure in subjects with thyrotoxicosis in a black community. Vasc Health Risk Manag. 2010 Aug 09;6:473-7. PMC free article: PMC2922308 PubMed: 20730063
  20. Schoenenberger AW, Schoenenberger-Berzins R, der Maur CA, Suter PM, Vergopoulos A, Erne P. Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study. Clin Res Cardiol. 2012 Mar;101(3):159-64. PubMed: 22057652
  21. DiNicolantonio JJ, Liu J, O’Keefe JH. Thiamine and Cardiovascular Disease: A Literature Review. Prog Cardiovasc Dis. 2018 May-Jun;61(1):27-32. PubMed: 29360523
  22. Reddy YNV, Melenovsky V, Redfield MM, Nishimura RA, Borlaug BA. High-Output Heart Failure: A 15-Year Experience. J Am Coll Cardiol. 2016 Aug 02;68(5):473-482. PubMed: 27470455
  23. Chayanupatkul M, Liangpunsakul S. Cirrhotic cardiomyopathy: review of pathophysiology and treatment. Hepatol Int. 2014 Jul;8(3):308-15. PMC free article: PMC4160726 PubMed: 25221635
  24. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW., American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020 Mar 03;141(9):e139-e596. PubMed: 31992061
  25. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):6A-13A. PubMed: 8376698
  26. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017 Mar 07;135(10):e146-e603. PMC free article: PMC5408160 PubMed: 28122885
  27. Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, AlHabib KF, Dans A, Lopez-Jaramillo P, Avezum A, Lanas F, Oguz A, Kruger IM, Diaz R, Yusoff K, Mony P, Chifamba J, Yeates K, Kelishadi R, Yusufali A, Khatib R, Rahman O, Zatonska K, Iqbal R, Wei L, Bo H, Rosengren A, Kaur M, Mohan V, Lear SA, Teo KK, Leong D, O’Donnell M, McKee M, Dagenais G. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020 Mar 07;395(10226):795-808. PMC free article: PMC8006904 PubMed: 31492503
  28. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodelling. Lancet. 2006 Jan 28;367(9507):356-67. PubMed: 16443044
  29. Kemp CD, Conte JV. The pathophysiology of heart failure. Cardiovasc Pathol. 2012 Sep-Oct;21(5):365-71. PubMed: 22227365
  30. Ait Mou Y, Bollensdorff C, Cazorla O, Magdi Y, de Tombe PP. Exploring cardiac biophysical properties. Glob Cardiol Sci Pract. 2015;2015:10. PMC free article: PMC4448074 PubMed: 26779498
  31. Abassi Z, Khoury EE, Karram T, Aronson D. Edema formation in congestive heart failure and the underlying mechanisms. Front Cardiovasc Med. 2022;9:933215. PMC free article: PMC9553007 PubMed: 36237903
  32. Prausmüller S, Arfsten H, Spinka G, Freitag C, Bartko PE, Goliasch G, Strunk G, Pavo N, Hülsmann M. Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HFrEF. J Am Heart Assoc. 2020 Jun 02;9(11):e015071. PMC free article: PMC7428996 PubMed: 32427034
  33. Docherty KF, Vaduganathan M, Solomon SD, McMurray JJV. Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF. JACC Heart Fail. 2020 Oct;8(10):800-810. PMC free article: PMC8837825 PubMed: 33004114
  34. Obokata M, Reddy YNV, Borlaug BA. Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: Understanding Mechanisms by Using Noninvasive Methods. JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 2):245-257. PMC free article: PMC6899218 PubMed: 31202759
  35. Kao DP, Lewsey JD, Anand IS, Massie BM, Zile MR, Carson PE, McKelvie RS, Komajda M, McMurray JJ, Lindenfeld J. Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response. Eur J Heart Fail. 2015 Sep;17(9):925-35. PMC free article: PMC4654630 PubMed: 26250359
  36. Harjola VP, Mullens W, Banaszewski M, Bauersachs J, Brunner-La Rocca HP, Chioncel O, Collins SP, Doehner W, Filippatos GS, Flammer AJ, Fuhrmann V, Lainscak M, Lassus J, Legrand M, Masip J, Mueller C, Papp Z, Parissis J, Platz E, Rudiger A, Ruschitzka F, Schäfer A, Seferovic PM, Skouri H, Yilmaz MB, Mebazaa A. Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2017 Jul;19(7):821-836. PMC free article: PMC5734941 PubMed: 28560717
  37. King M, Kingery J, Casey B. Diagnosis and evaluation of heart failure. Am Fam Physician. 2012 Jun 15;85(12):1161-8. PubMed: 22962896
  38. Ali AS, Rybicki BA, Alam M, Wulbrecht N, Richer-Cornish K, Khaja F, Sabbah HN, Goldstein S. Clinical predictors of heart failure in patients with first acute myocardial infarction. Am Heart J. 1999 Dec;138(6 Pt 1):1133-9. PubMed: 10577445
  39. Klein L, O’Connor CM, Leimberger JD, Gattis-Stough W, Piña IL, Felker GM, Adams KF, Califf RM, Gheorghiade M., OPTIME-CHF Investigators. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation. 2005 May 17;111(19):2454-60. PubMed: 15867182
  40. Kelder JC, Cramer MJ, van Wijngaarden J, van Tooren R, Mosterd A, Moons KG, Lammers JW, Cowie MR, Grobbee DE, Hoes AW. The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure. Circulation. 2011 Dec 20;124(25):2865-73. PubMed: 22104551
  41. Rørth R, Jhund PS, Yilmaz MB, Kristensen SL, Welsh P, Desai AS, Køber L, Prescott MF, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction. Circ Heart Fail. 2020 Feb;13(2):e006541. PubMed: 32065760
  42. Hacker M, Hoyer X, Kupzyk S, La Fougere C, Kois J, Stempfle HU, Tiling R, Hahn K, Störk S. Clinical validation of the gated blood pool SPECT QBS processing software in congestive heart failure patients: correlation with MUGA, first-pass RNV and 2D-echocardiography. Int J Cardiovasc Imaging. 2006 Jun-Aug;22(3-4):407-16. PubMed: 16328851
  43. Jain S, Londono FJ, Segers P, Gillebert TC, De Buyzere M, Chirinos JA. MRI Assessment of Diastolic and Systolic Intraventricular Pressure Gradients in Heart Failure. Curr Heart Fail Rep. 2016 Feb;13(1):37-46. PubMed: 26780916
  44. Cahill TJ, Ashrafian H, Watkins H. Genetic cardiomyopathies causing heart failure. Circ Res. 2013 Aug 30;113(6):660-75. PubMed: 23989711
  45. Peterson PN, Rumsfeld JS, Liang L, Albert NM, Hernandez AF, Peterson ED, Fonarow GC, Masoudi FA., American Heart Association Get With the Guidelines-Heart Failure Program. A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program. Circ Cardiovasc Qual Outcomes. 2010 Jan;3(1):25-32. PubMed: 20123668
  46. Lam CSP, Mulder H, Lopatin Y, Vazquez-Tanus JB, Siu D, Ezekowitz J, Pieske B, O’Connor CM, Roessig L, Patel MJ, Anstrom KJ, Hernandez AF, Armstrong PW., VICTORIA Study Group. Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial. J Am Heart Assoc. 2021 Nov 16;10(22):e021094. PMC free article: PMC8751950 PubMed: 34743540
  47. Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, Lam CSP, Ponikowski P, Voors AA, Jia G, McNulty SE, Patel MJ, Roessig L, Koglin J, O’Connor CM., VICTORIA Study Group. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2020 May 14;382(20):1883-1893. PubMed: 32222134
  48. Lucas C, Johnson W, Hamilton MA, Fonarow GC, Woo MA, Flavell CM, Creaser JA, Stevenson LW. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J. 2000 Dec;140(6):840-7. PubMed: 11099986
  49. Rider I, Sorensen M, Brady WJ, Gottlieb M, Benson S, Koyfman A, Long B. Disposition of acute decompensated heart failure from the emergency department: An evidence-based review. Am J Emerg Med. 2021 Dec;50:459-465. PubMed: 34500232

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *